Mutual of America Capital Management LLC Increases Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

Mutual of America Capital Management LLC boosted its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 18.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,275 shares of the technology company’s stock after buying an additional 13,418 shares during the quarter. Mutual of America Capital Management LLC owned approximately 0.42% of Simulations Plus worth $2,731,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in shares of Simulations Plus by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock worth $46,710,000 after acquiring an additional 12,636 shares in the last quarter. EntryPoint Capital LLC bought a new position in Simulations Plus in the first quarter worth about $57,000. Price T Rowe Associates Inc. MD lifted its position in shares of Simulations Plus by 5.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 10,048 shares of the technology company’s stock valued at $414,000 after buying an additional 562 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in shares of Simulations Plus during the first quarter valued at about $1,082,000. Finally, Silvercrest Asset Management Group LLC bought a new stake in shares of Simulations Plus in the 1st quarter valued at about $4,717,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Shares of SLP stock opened at $31.32 on Friday. The business has a fifty day moving average of $30.80 and a 200 day moving average of $38.31. Simulations Plus, Inc. has a 1 year low of $27.07 and a 1 year high of $51.22. The firm has a market capitalization of $628.59 million, a price-to-earnings ratio of 63.92 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. During the same period in the prior year, the company earned $0.18 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. As a group, equities research analysts expect that Simulations Plus, Inc. will post 1.12 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total value of $553,200.00. Following the completion of the transaction, the director now directly owns 3,462,584 shares in the company, valued at $95,775,073.44. The trade was a 0.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last ninety days, insiders sold 60,750 shares of company stock valued at $1,905,655. 20.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

SLP has been the subject of a number of analyst reports. KeyCorp initiated coverage on shares of Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 target price for the company. StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. BTIG Research dropped their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. Stephens assumed coverage on Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price on the stock. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $51.40.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.